Your browser doesn't support javascript.
loading
Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases.
Gencheva, Radosveta; Cheng, Qing; Arnér, Elias S J.
Affiliation
  • Gencheva R; Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden.
  • Cheng Q; Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden.
  • Arnér ESJ; Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden; Department of Selenoprotein Research, National Tumor Biology Laboratory, National Institute of Oncology, 1122, Budapest, Hungary. Electronic address: elias.arner@ki.se.
Free Radic Biol Med ; 190: 320-338, 2022 09.
Article in En | MEDLINE | ID: mdl-35987423
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thioredoxin-Disulfide Reductase / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Free Radic Biol Med Journal subject: BIOQUIMICA / MEDICINA Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thioredoxin-Disulfide Reductase / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Free Radic Biol Med Journal subject: BIOQUIMICA / MEDICINA Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: United States